Alternative trading system (ATS) NEXTRADE (NXT) said on the 24th that it has selected a total of 700 issues—375 KOSPI issues and 325 KOSDAQ issues—as trade matching targets for the first quarter of next year (January to March).

Kim Hak-su, CEO of NEXTRADE (NXT). /Courtesy of News1

Along with 350 issues that make up the KOSPI200 index and the KOSDAQ150 index, the top 175 by market capitalization on the KOSPI and KOSDAQ markets, respectively, were selected as tradable issues.

However, to manage trading limits smoothly, issues with low share prices that see large changes in volume were excluded, taking into account the price distribution of listed issues.

As a result of the selection, 120 issues, including Samsung Bioepis Holdings and Aimed Bio, were newly added. A total of 477 issues, including Samsung Electronics and Alteogen, remained on the trade matching list from the previous quarter.

Among the previous quarter's trading-target issues, 103 that had been excluded for the purpose of managing volume limits under the Financial Investment Services and Capital Markets Act, including Korea Electric Power Corporation and EcoPro, were re-included. In contrast, 152 issues, including SK Networks and PATRON, were excluded.

NEXTRADE (NXT) said, "While the principle is to select trade matching targets every quarter, since the third quarter we have not changed the targets but have reduced the number of issues to comply with volume regulations," adding, "As a result, as of the end of December, we expect to be in compliance with the limit regulations."

Earlier, NEXTRADE (NXT) excluded 165 issues from trading targets in four rounds starting in August this year to comply with the rule that the average daily volume over the past six months must not exceed 15% of the Korea Exchange (KRX) volume.

NEXTRADE (NXT) said, "By monitoring the daily and periodic volume ratios, we will proactively comply with the limit regulations while keeping the number of trade matching target issues within 700 to meet investor demand."

※ This article has been translated by AI. Share your feedback here.